Trial
NCT02407821
The Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment (RoSIE)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
McMaster University; Unity Health Toronto; University of Toronto
Condition
End Stage Renal Disease
Intervention
Escitalopram
Why stopped
Poor enrolment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-11